Delisting Determination, The Nasdaq Stock Market, LLC, October 12, 2023,
Histogen Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined to remove
from listing the securities of Histogen Inc., effective
at the opening of the trading session on October 23, 2023.
Based on review of information provided by the Company, Nasdaq
Staff determined that the Company no longer qualified for listing
on the Exchange pursuant to Listing Rule 5101.
The Company was notified of the Staff determination on
September 26, 2023. The Company did not appeal the Staff determination
to the Hearings Panel. The Company securities were suspended on
October 5, 2023. The Staff determination to delist the Company
securities became final on October 5, 2023.